|
de la Morena-Barrio ME, Gindele R, Bravo-Perez C, Ilonczai P, Zuazu I, Speker M, Olah Z, Rodriguez-Sevilla JJ, Entrena L, Infante MS, de la Morena-Barrio B, Garcia JM, Schlammadinger A, Cifuentes-Riquelme R, Mora-Casado A, Minano A, Padilla J, Vicente V, Corral J, Bereczky Z. High penetrance of inferior vena cava system atresia in severe thrombophilia caused by homozygous antithrombin Budapest 3 variant: Description of a new syndrome. Am J Hematol. 2021 Nov 1;96(11):1363-1373. doi: 10.1002/ajh.26304. Epub 2021 Aug 12. PubMed PMID: 34324211.
AÑO: 2021; IF: 13.265
|
34324211
|
de la Morena-Barrio ME, Bravo-Perez C, Minano A, de la Morena-Barrio B, Fernandez-Perez MP, Bernal E, Gomez-Verdu JM, Herranz MT, Vicente V, Corral J, Lozano ML. Prognostic value of thrombin generation parameters in hospitalized COVID-19 patients. Sci Rep. 2021 Apr 8;11(1):7792. doi: 10.1038/s41598-021-85906-y. PubMed PMID: 33833254; PubMed Central PMCID: PMC8032761.
AÑO: 2021; IF: 4.996
|
|
de la Morena-Barrio ME, Bravo-Perez C, de la Morena-Barrio B, Orlando C, Cifuentes R, Padilla J, Minano A, Herrero S, Marcellini S, Revilla N, Bernal E, Gomez-Verdu JM, Jochmans K, Herranz MT, Vicente V, Corral J, Lozano ML. A pilot study on the impact of congenital thrombophilia in COVID-19. Eur J Clin Invest. 2021 May;51(5):e13546. doi: 10.1111/eci.13546. Epub 2021 Mar 25. No abstract available. PubMed PMID: 33738814; PubMed Central PMCID: PMC8250296.
AÑO: 2021; IF: 5.722
|
|
Lopez-Galvez R, de la Morena-Barrio ME, Minano A, Pathak M, Marcos C, Emsley J, Caballero T, Lopez-Trascasa M, Vicente V, Corral J, Lopez-Lera A. Thrombin in the Activation of the Fluid Contact Phase in Patients with Hereditary Angioedema Carrying the F12 P.Thr309Lys Variant. Clin Rev Allergy Immunol. 2021 Jun;60(3):357-368. doi: 10.1007/s12016-021-08840-x. Epub 2021 Mar 16. PubMed PMID: 33725261.
AÑO: 2021; IF: 10.817
|
|
Nowak W, Trelinski J, Wypasek E, de la Morena-Barrio B, de la Morena-Barrio ME, Corral J. New SERPINC1 gene mutations in patients with antithrombin deficiency: antithrombin Lodz I, II, III, and IV. Pol Arch Intern Med. 2022 Jan 28;132(1):16158. doi: 10.20452/pamw.16158. Epub 2021 Dec 1. No abstract available. PubMed PMID: 34851072.
AÑO: 2022; IF: 4.8
|